Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.
Al Hadidi S, Ababneh OE, Schinke CD, Thanendrarajan S, Bailey C, Smith R, Panozzo S, Alapat D, Cottler-Fox M, Tricot G, Shaughnessy JD Jr, Zhan F, Sawyer J, Barlogie B, Zangari M, van Rhee F.
Al Hadidi S, et al. Among authors: cottler fox m.
Blood Adv. 2024 Feb 13;8(3):703-707. doi: 10.1182/bloodadvances.2023011601.
Blood Adv. 2024.
PMID: 38052037
Free PMC article.